230 related articles for article (PubMed ID: 22102710)
21. Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma.
Desmots F; Roussel M; Pangault C; Llamas-Gutierrez F; Pastoret C; Guiheneuf E; Le Priol J; Camara-Clayette V; Caron G; Henry C; Belaud-Rotureau MA; Godmer P; Lamy T; Jardin F; Tarte K; Ribrag V; Fest T
Clin Cancer Res; 2019 Jan; 25(2):735-746. PubMed ID: 30348636
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
Zhang X; Li F; Zhu L
Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
[TBL] [Abstract][Full Text] [Related]
24. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
[TBL] [Abstract][Full Text] [Related]
25. The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.
Battistella M; Romero M; Castro-Vega LJ; Gapihan G; Bouhidel F; Bagot M; Feugeas JP; Janin A
J Invest Dermatol; 2015 Jun; 135(6):1659-1667. PubMed ID: 25634356
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
[TBL] [Abstract][Full Text] [Related]
27. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B
Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165
[TBL] [Abstract][Full Text] [Related]
28. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.
Misiewicz-Krzeminska I; Sarasquete ME; Quwaider D; Krzeminski P; Ticona FV; Paíno T; Delgado M; Aires A; Ocio EM; García-Sanz R; San Miguel JF; Gutiérrez NC
Haematologica; 2013 Apr; 98(4):640-8. PubMed ID: 23100276
[TBL] [Abstract][Full Text] [Related]
29. miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
Colamaio M; Puca F; Ragozzino E; Gemei M; Decaussin-Petrucci M; Aiello C; Bastos AU; Federico A; Chiappetta G; Del Vecchio L; Torregrossa L; Battista S; Fusco A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E59-69. PubMed ID: 25238203
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
[TBL] [Abstract][Full Text] [Related]
31. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
32. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
33. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
[TBL] [Abstract][Full Text] [Related]
34. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.
Peng HY; Jiang SS; Hsiao JR; Hsiao M; Hsu YM; Wu GH; Chang WM; Chang JY; Jin SL; Shiah SG
Mol Oncol; 2016 Jun; 10(6):895-909. PubMed ID: 27038552
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
[TBL] [Abstract][Full Text] [Related]
36. The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.
Fassina A; Marino F; Siri M; Zambello R; Ventura L; Fassan M; Simonato F; Cappellesso R
Lab Invest; 2012 Nov; 92(11):1574-82. PubMed ID: 22964854
[TBL] [Abstract][Full Text] [Related]
37. hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of
Drobna M; Szarzyńska B; Jaksik R; Sędek Ł; Kuchmiy A; Taghon T; Van Vlierberghe P; Szczepański T; Witt M; Dawidowska M
Cells; 2020 May; 9(5):. PubMed ID: 32380791
[TBL] [Abstract][Full Text] [Related]
38. Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.
Arribas AJ; Campos-Martín Y; Gómez-Abad C; Algara P; Sánchez-Beato M; Rodriguez-Pinilla MS; Montes-Moreno S; Martinez N; Alves-Ferreira J; Piris MA; Mollejo M
Blood; 2012 Jan; 119(3):e9-e21. PubMed ID: 22110251
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-363-3p/p21(Cip1/Waf1) axis is regulated by HIF-2α in mediating stemness of melanoma cells.
Hao T; Li CX; Ding XY; Xing XJ
Neoplasma; 2019 May; 66(3):427-436. PubMed ID: 30784290
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]